Structural characterization of rhamnogalacturonan-I purified from and its anti-lung cancer efficacy via immunostimulation.

Food Sci Biotechnol

Department of Food Science and Biotechnology, Kyonggi University, Suwon, 16227 Republic of Korea.

Published: December 2024

AI Article Synopsis

  • The study focuses on turmeric-derived polysaccharides (TPE-I) and their structural, immunostimulatory, and anti-cancer properties, identifying TPE-I as having a rhamnogalacturonan (RG)-I structure.
  • Results showed that the cleavage of TPE-I led to reduced macrophage cytokine secretion, while TPE-I treatment increased the efficiency of natural killer (NK) cells and cytotoxic T lymphocytes against tumors.
  • TPE-I was found to effectively inhibit lung cancer in mice, even when NK cell activity was impaired, suggesting that turmeric contains significant bioactive compounds beyond just curcuminoids.

Article Abstract

Unlabelled: In this study, we investigated the structural characteristics, immunostimulatory activities, and anti-cancer effects of turmeric-derived polysaccharides (TPE-I). Several results related to the structural features revealed that TPE-I possesses a typical rhamnogalacturonan (RG)-I structure. Furthermore, macrophage cytokine secretion was significantly reduced by partial side chain and main chain cleavage of TPE-I via sequential enzymatic and chemical degradation. In contrast, the administration of TPE-I effectively enhanced the cytotoxic effects of natural killer (NK) cells and cytotoxic T lymphocytes against tumor cells. Additionally, the administration of TPE-I potently inhibited lung cancer induced by Colon26-M3.1, and this efficacy persisted even in mice with NK cell function blocked by anti-asialo GM1 antibody. Consequently, it was confirmed that TPE-I, a RG-I type polysaccharide purified from turmeric, has potent anticancer effects which are closely related to immunostimulation. The results of this study support the hypothesis that curcuminoids are not the only bioactive substances present in turmeric.

Supplementary Information: The online version contains supplementary material available at 10.1007/s10068-024-01595-z.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11525377PMC
http://dx.doi.org/10.1007/s10068-024-01595-zDOI Listing

Publication Analysis

Top Keywords

administration tpe-i
8
tpe-i
6
structural characterization
4
characterization rhamnogalacturonan-i
4
rhamnogalacturonan-i purified
4
purified anti-lung
4
anti-lung cancer
4
cancer efficacy
4
efficacy immunostimulation
4
immunostimulation unlabelled
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!